Skip to content
Explore comprehensive guides on international living, expat…

Patients Stopping Weight-Loss Jabs Regain Pounds Four Times Faster Than Those on Conventional Diets

Illustration of medical syringe and weighing machine
Weight management often requires long-term strategies.

Fresh analysis indicates that patients who discontinue new weight-loss injections like semaglutide or tirzepatide may regain reduced body mass far faster than those who stop conventional lifestyle plans.

Findings released in a major medical journal points out that while overweight people often shed about a fifth of their total mass while on the medication, the mass is regained at an estimated rate of nearly a kilo each month once they quit.

"Individuals using such treatments should be cognizant of the danger of fast rebound weight gain when the treatment concludes," cautioned researcher Dr. Susan Jebb.

That rate of regain suggests a reversion to starting weight within about 18 months.

Comparing Treatments

The research, which examined 37 of trials involving over 9,000 of participants, compared the effects of GLP-1 agonists with conventional dieting.

Researchers note that individuals who lose weight through lifestyle changes alone usually have a slower creep back—approximately 0.1 kg a month—post-intervention.

Explaining the Rapid Rebound

Nutrition scientists believe the mode of action of the drugs explains the amplified regain.

GLP-1 drugs mimic a body's own chemical called GLP-1, which moderates hunger.

"Sustained high doses of the hormone levels far above than the body's typical production may cause the system to generate a reduced amount of its own natural GLP-1, and could diminish responsiveness to its effects," noted Dr. Adam Collins, a dietetics researcher.

"Stopping of this hormone supplement results in appetite is no longer kept in check, making binge eating much more probable."

A Lifelong Issue?

Medical guidelines advise the injections for individuals with weight-linked health risks, alongside prescribed lifestyle changes.

Professionals say that, given the significant potential of weight regain, the therapy is often ongoing.

This view is echoed by drug manufacturers, who note that the results "underscore the chronic character of excess weight," comparing it to managing conditions like hypertension.

User Accounts

Individuals who have come off the medication report a intense resurgence of appetite.

"It was like a trigger flipping and you become starving," recalled one woman.

This challenge is compounded if individuals have not adopted sustainable dietary or behavioural modifications during therapy.

Significant Adoption

Figures suggest that a significant number of adults in the UK have used these injections in the past year, with demand remaining high.

  • Use is greater among women than males.
  • The 40s and 50s age group shows the highest level of interest.
  • Many obtain the drugs through private prescriptions rather than public health services.

In conclusion, researchers stress that while GLP-1 drugs are effective agents for shedding pounds, they are not a standalone fix and maintained weight loss relies on integrated behavioural changes.

About the author

Alan Martinez Jr.

Global nomad and expat coach with 10 years of experience helping people relocate and thrive internationally.

Best Global Nest Space

Type to search articles.